Compare Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) vs US Bancorp (USB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio-Rad Laboratories, Inc. Class A Common Stock vs US Bancorp — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $298.3 (market cap $8.02B), while US Bancorp trades at $62.98 (market cap $97.11B). The key difference: US Bancorp is far larger — about 12.1× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and US Bancorp pays a 3.34% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | USB | |
|---|---|---|
Market Cap | $8.02B | $97.11B |
Sector | Health | Financials |
52-Week High | $339.75 | $62.89 |
52-Week Low | $241.71 | $43.94 |
Enterprise Value | $7.84B | — |
Dividend Yield | — | 3.34% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
U.S. Bancorp (USB) trades at $62.34, near the lower end of analyst targets, with a modest daily decline. The stock shows bullish technical signals from moving averages and has consistently beaten earnings estimates in recent quarters. Revenue and net income have grown steadily, with 2025 net income reaching $7.57 billion. Recent news highlights new small business payment tools and positive earnings expectations for Q2 2026.
The outlook is supported by strong profitability and a favorable analyst consensus, but risks include elevated debt levels and interest rate sensitivity. The stock offers value with a P/E of 13.07 and a dividend, though net cash flow remains negative. Upside to the $67 consensus target depends on continued earnings execution amid economic uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bio-Rad Laboratories, Inc. Class A Common Stock
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →About US Bancorp
As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in well over 20 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.
Read more on USB →
